Invesco Ltd. Travere Therapeutics, Inc. Transaction History

Invesco Ltd.

$516 Billion
Q4 2024

A detailed history of Invesco Ltd. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 858,942 shares of TVTX stock, worth $19.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

858,942

Previous 365,206 135.19%

Holding current value

$19.7 Million

Previous $5.11 Million 192.86%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$13.65 - $19.85 $6.74 Million - $9.8 Million	493,736 Added 135.19%	858,942 $15 Million
Q3 2024 Nov 12, 2024	BUY	$7.89 - $15.21 $2.64 Million - $5.08 Million	334,226 Added 1078.84%	365,206 $5.11 Million
Q2 2024 Aug 13, 2024	SELL	$5.26 - $8.28 $11,608 - $18,273	-2,207 Reduced 6.65%	30,980 $254,000
Q1 2024 May 14, 2024	SELL	$7.18 - $9.82 $156,524 - $214,076	-21,800 Reduced 39.65%	33,187 $255,000
Q4 2023 Feb 12, 2024	SELL	$5.44 - $9.5 $4.12 Million - $7.2 Million	-758,265 Reduced 93.24%	54,987 $494,000
Q3 2023 Nov 13, 2023	BUY	$7.64 - $17.25 $865,230 - $1.95 Million	113,250 Added 16.18%	813,252 $7.27 Million
Q2 2023 Aug 11, 2023	BUY	$15.3 - $22.61 $2.29 Million - $3.38 Million	149,546 Added 27.17%	700,002 $10.8 Million
Q1 2023 May 12, 2023	SELL	$17.82 - $22.89 $110,840 - $142,375	-6,220 Reduced 1.12%	550,456 $12.4 Million
Q4 2022 Feb 13, 2023	BUY	$18.47 - $26.14 $2.2 Million - $3.11 Million	119,090 Added 27.22%	556,676 $11.7 Million
Q3 2022 Nov 14, 2022	SELL	$22.91 - $28.63 $1.42 Million - $1.77 Million	-61,900 Reduced 12.39%	437,586 $10.8 Million
Q2 2022 Aug 15, 2022	BUY	$20.94 - $30.01 $2.1 Million - $3 Million	100,129 Added 25.07%	499,486 $12.1 Million
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $2.64 Million - $3.42 Million	-111,844 Reduced 21.88%	399,357 $10.3 Million
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $11.5 Million - $14.8 Million	474,229 Added 1282.67%	511,201 $15.9 Million
Q3 2021 Nov 15, 2021	BUY	$12.98 - $25.03 $37,226 - $71,786	2,868 Added 8.41%	36,972 $897,000
Q2 2021 Aug 17, 2021	SELL	$14.11 - $26.4 $5.04 Million - $9.42 Million	-356,987 Reduced 91.28%	34,104 $497,000
Q1 2021 May 17, 2021	BUY	$23.37 - $31.77 $8.43 Million - $11.5 Million	360,928 Added 1196.59%	391,091 $9.77 Million
Q4 2020 Feb 16, 2021	BUY	$19.17 - $27.87 $578,224 - $840,642	30,163 New	30,163 $822,000

Others Institutions Holding TVTX

# of Institutions

213

Shares Held

94M

Call Options Held

1.2M

Put Options Held

778K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.47B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account